Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
3.
Magy Onkol ; 62(3): 153-158, 2018 Sep 26.
Article in Hungarian | MEDLINE | ID: mdl-30256881

ABSTRACT

The standard treatment of papillary microcarcinomas (mPTC; ≤1 cm) regardless of their size, was similar to the advanced ones till the recent past: immediate surgery ± radioactive iodine (RAI) therapy. However, the American Thyroid Association (ATA) 2015 guidelines accept the active surveillance in selected cases. We performed a retrospective analysis on the clinical data of 103 patients with PTmC in a single (62.1%) or multiple nodes (37.9%), treated with immediate surgery followed in most cases by postoperative RAI between 2001 and 2010. N stage of the neck was pN0 in 81, and pN+ in 22 patients. Survival probability was significantly related to age (p<0.001), TSH level (p=0.0347), N stage (p=0.0402) and need for neck dissection (p=0.0045). Overall survival at 5, 10, and 15 years was 95%, 89%, and 86%, while disease-specific mortality at 5 and 10 years was 3% and 5%, respectively. Our data show that immediate radical surgery with or without postoperative RAI yielded long-term survival similar to those published. Nevertheless, progression affecting mostly older men was not prevented by immediate surgery. Our findings do not contradict the acceptability of active surveillance recommended by the 2015 ATA Guidelines.


Subject(s)
Academies and Institutes , Carcinoma, Papillary/therapy , Iodine Radioisotopes/therapeutic use , Medical Oncology , Thyroid Neoplasms/therapy , Thyroidectomy , Aged , Carcinoma, Papillary/drug therapy , Carcinoma, Papillary/surgery , Combined Modality Therapy , Female , Humans , Hungary , Male , Retrospective Studies , Survival Rate , Thyroid Neoplasms/drug therapy , Thyroid Neoplasms/surgery
4.
Orv Hetil ; 156(41): 1661-6, 2015 Oct 11.
Article in Hungarian | MEDLINE | ID: mdl-26551169

ABSTRACT

INTRODUCTION: The methods available for the diagnosis of thyroid nodules include physical examination, imaging, laboratory and fine-needle aspiration cytology tests. AIM: The aim of this study was to determine the quality assurance of fine-needle aspiration cytology of thyroid nodules. METHOD: Cytology results were rated to 6 categories according to the Bethesda System for Reporting Thyroid Cytopathology (2008) (I. nondiagnostic; II. benign; III. atypia of undetermined significance; IV. follicular neoplasia; V. suspicious for malignancy; VI. malignant). All cytology reports were compared with the final histology diagnosis. RESULTS: A total of 1384 patient with thyroid nodule underwent fine-needle aspiration biopsy cytology. Smears were classified I. inadequate in 214 (15.9%); II. benign 986; III. atypical 56; IV. follicular neoplasm 41; V. suspicious for malignancy 18; VI. malignant 33 cases. Two hundred and twenty seven (16.8%) of the cases were operated and histologically verified. The positive predictive value in the benign category was 98.25% and in the malignant 88.46%. The sensitivity of the follicular neoplasm was 66.67%. CONCLUSION: The results suggest that fine-needle aspiration cytology of thyroid nodules using the Bethesda System for Reporting Thyroid Cytopathology has a high diagnostic accuracy. The auditing values of the results meet the proposed threshold values.


Subject(s)
Biopsy, Fine-Needle , Medical Records/standards , Point-of-Care Testing , Quality Assurance, Health Care , Thyroid Gland/pathology , Thyroid Nodule/diagnosis , Adult , Aged , Aged, 80 and over , Biopsy, Fine-Needle/standards , Carcinoma/diagnosis , Female , Humans , Male , Middle Aged , Pathology, Clinical/standards , Point-of-Care Testing/standards , Predictive Value of Tests , Sensitivity and Specificity , Thyroid Neoplasms/diagnosis , Thyroid Nodule/pathology
5.
Magy Seb ; 68(4): 173-5, 2015 Aug.
Article in Hungarian | MEDLINE | ID: mdl-26284802

ABSTRACT

INTRODUCTION: The presence of a substernal goiter which compresses the adjacent structures is per se an indication for resection, mostly total thyreoidectomy should be performed either by a head and neck or general surgeon. In about 1-10% of the cases the goiter is located behind the sternum, and the removal requires different surgical technique. MATERIALS AND METHODS: Authors operated 182 patients between 2000-2014 with substernal goiter which all reached the level of the jugulum. The 182 cases were examined retrospectively. RESULTS: All the patients were symptomatic with choking and dyspnea. In 31 cases neck ultrasound were performed, in 7 cases neck MRI and in 138 cases neck-upper mediastinal CT scan were indicated to discover the real situation of the lobes. 15 patients had previous partial thyreoidectomy. Acervical approach was used in 175 cases, 7 patients required median sternotomy to complete the operation. Transient recurrent laryngeal nerve palsy occurred in 1 patient, permanent RLNP in 3. Nine lesions were malignant, 173 were benign. CONCLUSION: Choking and dyspnea are the most common symptoms of substernal goiter. CT scan is an important preoperative evaluation, while it helps not only to define the position of the thyroid lobes, but also put the right operating team together. Although most of the retrosternal goiters can be removed by a cervical approach, some of them need additional incisions. Hence, it is important to have a thoracic surgeon available. Reviewing the Hungarian literature the authors have not found any other study examining so many patients.

6.
Pathol Oncol Res ; 21(4): 1091-9, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25920367

ABSTRACT

Pilot studies have shown promising results in characterizing head and neck tumors (HNT) using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), differentiating between malignant and benign lesions and evaluating changes in response to chemoradiotherapy (CRT). Our aim was to find DCE-MRI parameters, biomarkers in evaluating the post-CRT status. Two hundred and five patients with head and neck lesions were examined with DCE-MRI sequences. The time intensity curves (TIC) were extracted and processed to acquire time-to-peak (TTP), relative maximum enhancement (RME), relative wash-out (RWO), and two new parameters attack and decay. These parameters were analyzed using univariate tests in SPSS (Statistical Package for the Social Sciences, version 17, SPSS Inc. Chicago, USA) to identify parameters that could be used to infer tumor malignancy and post-CRT changes. Multiple parameters of curve characteristics were significantly different between malignant tumors after CRT (MACRT) and changes caused by CRT. The best-performing biomarkers were the attack and the decay. We also found multiple significant (p < 0.05) parameters for both the benign and malignant status as well as pre- and post-CRT status. Our large cohort of data supports the increasing role of DCE-MRI in HNT differentiation, particularly for the assessment of post-CRT status along with accurate morphological imaging.


Subject(s)
Biomarkers/metabolism , Head and Neck Neoplasms/diagnosis , Head and Neck Neoplasms/pathology , Precancerous Conditions/diagnosis , Precancerous Conditions/pathology , Chemoradiotherapy/methods , Diagnosis, Differential , Head and Neck Neoplasms/metabolism , Humans , Magnetic Resonance Imaging/methods , Precancerous Conditions/metabolism
7.
Magy Seb ; 65(6): 426-9, 2012 Dec.
Article in Hungarian | MEDLINE | ID: mdl-23229035

ABSTRACT

Authors present a case of a 52-year-old female patient, who underwent an emergency tracheostomy due to life threatening dyspnoea caused by an external compression of a large goiter. Total thyreoidectomy needed to be carried out later, too. Since the atypical tracheostomy did not close spontaneously a reconstruction was planned. A part of the anterior wall of the trachea needed to be replaced, which was done by an osteocutaneous flap on raised on the supraclavicular artery. An island on the artery was harvested with a thin bone chip taken from the coracoid process of the clavicle, which was rotated into the defect then. The bone chip was sutured to the trachea wall and the donor site was closed primarily. Having reviewed the literature the authors propose the application of this flap in a wide range of cases. The advantages of this flap are the satisfactory functional and cosmetic results, as well as the fact that the donor site does not need skin grafting.


Subject(s)
Cutaneous Fistula/surgery , Fistula/surgery , Surgical Flaps , Tracheal Diseases/surgery , Tracheostomy/adverse effects , Clavicle , Female , Humans , Middle Aged , Plastic Surgery Procedures/methods , Skin Transplantation , Surgical Flaps/blood supply , Treatment Outcome
8.
Magy Onkol ; 52(3): 261-7, 2008 Sep.
Article in Hungarian | MEDLINE | ID: mdl-18845496

ABSTRACT

In Hungary the number of oral and pharyngeal cancers is alarmingly high. While the mortality rate in 1955 was 282, by 2005 it rose to 1567. However, in the last 1-2 years stagnation can be observed. Nevertheless, even now significant proportions of men and women are involved. Alcohol consumption and smoking are invariably the leading causes, but one cannot disregard the shortcomings of oral cancer screenings, either. Unfortunately, drastic changes in this field are not likely to occur in the near future. Numerous solutions have been developed for the replacement of soft tissue. In our article, we describe and evaluate four of them. When using these techniques, we were often successful in replacing soft tissue deficiencies.


Subject(s)
Mouth Neoplasms/surgery , Oral Surgical Procedures/methods , Plastic Surgery Procedures/methods , Surgical Flaps , Adult , Aged , Alcohol Drinking/adverse effects , Female , Forearm/surgery , Humans , Hungary/epidemiology , Male , Middle Aged , Mouth Neoplasms/epidemiology , Mouth Neoplasms/etiology , Pectoralis Muscles/surgery , Smoking/adverse effects , Treatment Outcome
9.
Magy Onkol ; 52(3): 279-81, 2008 Sep.
Article in Hungarian | MEDLINE | ID: mdl-18845498

ABSTRACT

Oral cancer incidence in Hungary is strikingly high, even by international standards. In most cases the tumours are to be treated in advanced stage. Hence it follows that we are often forced to remove a part of the mandible, too. We usually use a fibula free flap to reconstruct the bone deficiency. In this paper we report on our clinical experience with fibula free flap.


Subject(s)
Fibula/transplantation , Mandible/surgery , Mouth Neoplasms/surgery , Oral Surgical Procedures/methods , Surgical Flaps , Adult , Aged , Female , Humans , Male , Middle Aged , Treatment Outcome
10.
Magy Onkol ; 52(2): 171-6, 2008 Jun.
Article in Hungarian | MEDLINE | ID: mdl-18640893

ABSTRACT

In spite of the continued expansion of non-surgical therapeutic modalities surgery still plays an important role in the treatment of head and neck cancer. Parallel with the use of conventional approaches, more sophisticated surgical approaches, like the use of laser in oncologic surgery, appeared with a more favorable outcome. Laser is a precise surgical tool, particularly when coupled to an operating microscope (with a variable spot size micromanipulator), allowing microprecision and hemostatic ability. The benefits of the use of laser are: bloodless operation field, high hit probability, "no touch" technique, ablasticity, support of tissue repair, and the lack of edema and scar formation. Between 1981 and 2008, 7934 surgical procedures were performed at the Department of Head and Neck Surgery, National Institute of Oncology, Budapest, Hungary. The aim is to present our results and experience with laser surgery of cutaneous lesions of the head and neck, oral, pharyngeal and laryngeal pathologies including cases of laryngotracheal stenosis.


Subject(s)
Head and Neck Neoplasms/surgery , Laser Therapy , Academies and Institutes , Adult , Aged , Cicatrix/etiology , Female , Head and Neck Neoplasms/drug therapy , Head and Neck Neoplasms/pathology , Head and Neck Neoplasms/radiotherapy , Humans , Hungary , Laryngeal Neoplasms/surgery , Laryngostenosis/surgery , Male , Middle Aged , Mouth Neoplasms/surgery , Neoplasm Staging , Skin Neoplasms/surgery
11.
Magy Onkol ; 48(1): 27-34, 2004.
Article in Hungarian | MEDLINE | ID: mdl-15105893

ABSTRACT

Serum thyroglobulin (Tg) is a suitable marker for differentiated thyroid carcinoma following total thyroid ablation. Between 1998 and 2003, serum samples from 715 papillary and 179 follicular tumor patients treated with total/nearly total thyroidectomy and radioiodine ablation therapy were collected. According to the "Guidelines for Oncotherapy in Hungary", serum Tg, antithyroglobulin antibody (TgAb), TSH and FT4 levels were measured in periods of 3 months following the first treatment and of 6 months after 2 years. In the present work the prognostic value of Tg and TgAb data of cancer patients with hormone substitution therapy were evaluated individually and retrospectively. Serum Tg and TgAb concentrations were measured with a highly sensitive immunoradiometric (IRMA) method, and with a second generation, broad epitope specificity competitive radioimmunoassay, respectively. TSH levels determined by fourth generation LIAISON kit were in a range of 0.05-0.10 mIU/L. Accuracy of measuring of Tg <1 ng/ml made it possible to select the low cut-off level (Tg <2 ng/ml) following total thyroidectomy. In the predominant part of TSH-suppressed patients (746/774, 96%) the serum Tg concentration was below the cut-off level of 2 ng/ml. The sensitivity of Tg determination in 59 TSH-suppressed thyroid cancer patients with lung and bone metastases was as high as 86 to 100%. On the contrary, the number of false negative data was high in cases with lymph node metastases of papillary cancer, and sensitivity did not exceed 62%. Specificity and sensitivity of Tg in TgAb negative patients were 91 to 100%. Based on our results it could be concluded that measuring of Tg and TgAb, using a current IRMA method and a second generation RIA kit, proved to be effective tools for the postoperative monitoring of differentiated thyroid tumours. It has to be noted that determination of TgAb is highly recommended for the adequate interpretation of serum Tg levels. Persistently high and/or increasing serum TgAb concentration with low Tg result had a diagnostic value during the follow-up and can be connected with the recurrence or persistence of the differentiated thyroid cancer.


Subject(s)
Autoantibodies/blood , Carcinoma, Papillary, Follicular/immunology , Carcinoma, Papillary/immunology , Thyroglobulin/blood , Thyroglobulin/immunology , Thyroid Neoplasms/immunology , Adult , Aged , Carcinoma, Papillary/radiotherapy , Carcinoma, Papillary/surgery , Carcinoma, Papillary, Follicular/radiotherapy , Carcinoma, Papillary, Follicular/surgery , Female , Humans , Immunoradiometric Assay , Male , Middle Aged , Predictive Value of Tests , Radioimmunoassay , Retrospective Studies , Sensitivity and Specificity , Thyroid Neoplasms/radiotherapy , Thyroid Neoplasms/surgery
12.
Pathol Oncol Res ; 10(1): 42-6, 2004.
Article in English | MEDLINE | ID: mdl-15029261

ABSTRACT

Positron emission tomographic (PET) investigations were performed to obtain in vivo information on symptomless radiation-induced pathological changes in the human spinal cord. PET investigations were carried out prior to radiotherapy and during the regular follow-up in an early hypopharyngeal cancer patient (the spinal cord was irradiated with a biologically effective dose of 80 Gy2), with [18F]fluorodeoxyglucose (FDG), [11C]methionine and [15O]butanol as tracers; radiosensitivity and electroneuronographic (ENG) studies were also performed. A very low background FDG accumulation (mean standardized uptake values, i.e. SUV: 0.84) was observed in the spinal cord before the initiation of radiotherapy. An increased FDG uptake was measured 2 months after the completion of radiotherapy (mean SUV: 1.69), followed by a fall-off, as measured 7 months later (mean SUV: 1.21). By 44 months after completion of irradiation, the FDG accumulation in the irradiated segments of the spinal cord had decreased to a level very close to the initial value (mean SUV: 1.11). The simultaneous [15O]butanol uptake results demonstrated a set of perfusion changes similar to those observed in connection with the FDG accumulation. The patient exhibited an extremely low [11C]methionine uptake within the irradiated and the nonirradiated spinal cord during the clinical course. She has not had any neurological symptoms, and the results of central ENG measurements before radiotherapy and 2 months following its completion proved normal. Radiobiological investigations did not reveal unequivocal signs of an increased radiosensitivity. A transitory increased spinal cord FDG uptake following radiotherapy may be related to the posttherapeutic mild inflammatory and regenerative processes. The normal [11C]methionine accumulation observed is strong evidence against intensive cell proliferation. The high degree of normalization of the temporarily increased FDG uptake of the irradiated spinal cord segments by 44 months is in good agreement with the results of monkey studies, which demonstrated a nearly complete recovery from radiation-induced spinal cord injury.


Subject(s)
Radiation Injuries/diagnostic imaging , Radiopharmaceuticals , Radiotherapy/adverse effects , Spinal Cord/radiation effects , Butanols/metabolism , Cell Survival/radiation effects , Dose-Response Relationship, Radiation , Female , Fibroblasts/metabolism , Fibroblasts/radiation effects , Fluorodeoxyglucose F18 , Humans , Hypopharyngeal Neoplasms/radiotherapy , Methionine/metabolism , Middle Aged , Radiation Injuries/etiology , Spinal Cord/diagnostic imaging , Tomography, Emission-Computed/methods
13.
Pathol Oncol Res ; 8(2): 93-104, 2002.
Article in English | MEDLINE | ID: mdl-12172572

ABSTRACT

UNLABELLED: The relatively benign, but occasionally rapidly fatal clinical course of medullary thyroid cancer (MTC) has raised the need for individual survival probability estimation. A retrospective study on 91 MTC clinical case histories with a mean follow-up of 6 years indicated prevalences of local, regional and distant residual tumor on primary care completion of 23%, 54% and 54%, respectively. Local, regional and distant relapses during follow-up occurred in 8%, 23% and 26% of the patients, with a cause-specific death in 26% of the cases. Prognostic factors statistically significantly influencing the cause-specific survival were selected by uni- and multivariate analysis. A Markov method-based model was developed for the estimation of individual time-dependent local, regional and distant relapse-free and cause-specific survival probability functions, with parameters numerically determined via a maximum likelihood procedure. These parameters include relative risk factors related to prognosticators, a residual or recurrent local/regional/distant tumor, and combinations of these entities. In multivariate studies, the patient s age and gender, the genetic basis of the dis-ease, lymph node involvement, the existence of a general symptom (diarrhoea) at presentation, and the dosage of external irradiation proved to be prognosticators. The cause-specific survival function of the study population indicated mean 5, 10 and 15-year survival probabilities of 69%, 62% and 58%. CONCLUSION: Survival probabilities can be predicted for extrastudy cases provided that the same laws and principles govern the clinical course of these cases and those comprising the study. For individual survival probability estimation, a Pascal program (MEDUPRED) was written and is available on the home page of the National Institute of Oncology, Budapest (www.oncol.hu).


Subject(s)
Carcinoma, Medullary/mortality , Markov Chains , Thyroid Neoplasms/mortality , Adult , Bone Neoplasms/radiotherapy , Bone Neoplasms/secondary , Bone Neoplasms/surgery , Carcinoma, Medullary/pathology , Carcinoma, Medullary/radiotherapy , Carcinoma, Medullary/surgery , Female , Humans , Liver Neoplasms/radiotherapy , Liver Neoplasms/secondary , Liver Neoplasms/surgery , Lung Neoplasms/radiotherapy , Lung Neoplasms/secondary , Lung Neoplasms/surgery , Lymph Node Excision , Male , Middle Aged , Models, Statistical , Neoplasm Recurrence, Local/radiotherapy , Neoplasm Recurrence, Local/surgery , Neoplasm Staging , Neoplasm, Residual/radiotherapy , Neoplasm, Residual/surgery , Prognosis , Retrospective Studies , Risk Factors , Survival Rate , Thyroid Neoplasms/pathology , Thyroid Neoplasms/radiotherapy , Thyroid Neoplasms/surgery
14.
Magy Onkol ; 46(4): 347-9, 2002.
Article in Hungarian | MEDLINE | ID: mdl-12563358

ABSTRACT

The ectopic thyroid gland occurring in the midline of the base of tongue is a rare developmental anomaly. It may cause differential diagnostic problems with real malignant tumor. Symptoms, if where are any: foreign-body-feeling, swallowing difficulties, dyspnea, articulation disorders, bleeding and hypothyroidism, but in many cases the diagnosis is accidental. We describe two cases of lingual thyroid gland operated in our department, and discuss the present trends of the treatment of this disease. We agree with most of the authors that only cases presenting with symptoms should be operated, and if possible the normal thyroid tissue should be replaced into the body. However, all discovered cases have to be followed to avoid late hormonal disturbances.


Subject(s)
Choristoma/diagnosis , Thyroid Gland , Tongue Diseases/diagnosis , Adult , Choristoma/surgery , Diagnosis, Differential , Female , Humans , Tongue Diseases/surgery , Tongue Neoplasms/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...